JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHI
876
DELISTED
INPHI CORPORATION
IPHI
| $62M | 0.01% |
1,693,249
+357,422
| +27% | +$14M |
|
877
Knight Transportation
KNX
$11.4B
| $61.7M | 0.01% |
1,410,543
-731,482
| -34% | -$30.1M |
|
878
Regal Rexnord
RRX
$11.9B
| $61.6M | 0.01% |
804,219
-663,772
| -45% | -$51.6M |
|
879
Casey's General Stores
CASY
$30.9B
| $61.4M | 0.01% |
548,090
-32,910
| -6% | -$3.76M |
|
|
DYN
880
DELISTED
Dynegy, Inc.
DYN
| $61.3M | 0.01% |
5,174,647
+170,204
| +3% | +$1.9M |
|
881
BlackLine
BL
$1.72B
| $60.9M | 0.01% |
1,856,291
+1,852,591
| +50,070% | +$64.9M |
|
|
VAR
882
DELISTED
Varian Medical Systems, Inc.
VAR
| $60.9M | 0.01% |
547,574
+197,051
| +56% | +$21.2M |
|
883
PUT
Caterpillar
CAT
$387B
| $60.9M | 0.01% |
386,200
+55,000
| +17% | +$7.63M |
|
884
CALL
ExxonMobil
XOM
$634B
| $60.8M | 0.01% |
727,200
+462,200
| +174% | +$38.2M |
|
|
JPEU
885
DELISTED
JPMorgan Diversified Return Europe Equity ETF
JPEU
| $60.8M | 0.01% |
1,008,000
-3,135
| -0.3% | -$191K |
|
886
State Street DoubleLine Total Return Tactical ETF
TOTL
$4B
| $60.8M | 0.01% |
1,250,234
+550,972
| +79% | +$26.9M |
|
887
ON Semiconductor
ON
$31.6B
| $60.8M | 0.01% |
2,902,077
-710,587
| -20% | -$14.5M |
|
|
OAK
888
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $60.7M | 0.01% |
1,442,969
+53,739
| +4% | +$2.38M |
|
889
State Street SPDR S&P Bank ETF
KBE
$1.71B
| $60.5M | 0.01% |
1,277,274
-641,000
| -33% | -$29.5M |
|
890
Kinsale Capital Group
KNSL
$8.51B
| $60.4M | 0.01% |
1,343,272
+18,017
| +1% | +$785K |
|
891
Brookfield
BN
$108B
| $60.4M | 0.01% |
3,890,790
+1,235,414
| +47% | +$18.7M |
|
892
PUT
Cisco
CSCO
$479B
| $60.3M | 0.01% |
1,575,700
-7,500
| -0.5% | -$268K |
|
|
ZEN
893
DELISTED
ZENDESK INC
ZEN
| $60.2M | 0.01% |
1,778,188
-196,878
| -10% | -$6.44M |
|
894
PUT
TripAdvisor
TRIP
$1.26B
| $59.7M | 0.01% |
+1,732,900
| New | +$62.6M |
|
|
CADE
895
DELISTED
Cadence Bank
CADE
| $59.5M | 0.01% |
1,891,510
+96,263
| +5% | +$3.09M |
|
|
TGP
896
DELISTED
Teekay LNG Partners L.P.
TGP
| $59.3M | 0.01% |
2,944,669
+457,074
| +18% | +$8.3M |
|
|
KND
897
DELISTED
Kindred Healthcare
KND
| $59M | 0.01% |
6,077,431
+2,504,747
| +70% | +$18.6M |
|
898
Canadian Imperial Bank of Commerce
CM
$108B
| $58.9M | 0.01% |
1,209,144
-219,212
| -15% | -$9.98M |
|
899
Lear
LEA
$8.18B
| $58.9M | 0.01% |
333,250
-140,087
| -30% | -$24.6M |
|
900
Acadia Pharmaceuticals
ACAD
$5.03B
| $58.4M | 0.01% |
1,939,380
+59,556
| +3% | +$1.9M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.